Loughborough University
Browse
Differentiation of mouse bone marrow derived stem cells toward microglia-like cells..pdf (1.89 MB)

Differentiation of mouse bone marrow derived stem cells toward microglia-like cells

Download (1.89 MB)
journal contribution
posted on 2014-12-04, 10:09 authored by Arnd Hinze, Alexandra StolzingAlexandra Stolzing
Background: Microglia, the macrophages of the brain, have been implicated in the causes of neurodegenerative diseases and display a loss of function during aging. Throughout life, microglia are replenished by limited proliferation of resident microglial cells. Replenishment by bone marrow-derived progenitor cells is still under debate. In this context, we investigated the differentiation of mouse microglia from bone marrow (BM) stem cells. Furthermore, we looked at the effects of FMS-like tyrosine kinase 3 ligand (Flt3L), astrocyte-conditioned medium (ACM) and GM-CSF on the differentiation to microglia-like cells.Methods: We assessed in vitro-derived microglia differentiation by marker expression (CD11b/CD45, F4/80), but also for the first time for functional performance (phagocytosis, oxidative burst) and in situ migration into living brain tissue. Integration, survival and migration were assessed in organotypic brain slices.Results: The cells differentiated from mouse BM show function, markers and morphology of primary microglia and migrate into living brain tissue. Flt3L displays a negative effect on differentiation while GM-CSF enhances differentiation.Conclusion: We conclude that in vitro-derived microglia are the phenotypic and functional equivalents to primary microglia and could be used in cell therapy. © 2011 Hinze and Stolzing; licensee BioMed Central Ltd.

History

School

  • Mechanical, Electrical and Manufacturing Engineering

Published in

BMC Cell Biology

Volume

12

Citation

HINZE, A. and STOLZING, A., 2011. Differentiation of mouse bone marrow derived stem cells toward microglia-like cells. BMC Cell Biology, 12:35, 10pp.

Publisher

© 2011 Hinze and Stolzing; licensee BioMed Central Ltd.

Version

  • VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution 2.0 Unported (CC BY 2.0) licence. Full details of this licence are available at: http://creativecommons.org/licenses/by/2.0/

Publication date

2011

Notes

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

eISSN

1471-2121

Language

  • en

Usage metrics

    Loughborough Publications

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC